ArticleThe Journal of pharmacology and experimental therapeutics2018

Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases.

Frank Hilberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.